Trials / Completed
CompletedNCT00259051
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
A Double-blind, Randomised, Parallel-group, Multicentre, Phase III Study to Investigate the Pharmacodynamic Effect by Assessment of the 24 Hours Intraesophageal pH Level, the Efficacy and Safety of Omeprazole 10mg and 20mg od in Patients With Non-erosive Reflux Disease (NERD).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (planned)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the pharmacodynamic effect of omeprazole n a Japanese non-erosive reflux disease population
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Omeprazole |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2004-08-01
- Completion
- 2004-08-01
- First posted
- 2005-11-29
- Last updated
- 2011-01-24
Locations
13 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00259051. Inclusion in this directory is not an endorsement.